23,338,039
Vote Records
27,979
Companies
11,817
Funds
4,051
Managers

Home › Companies › Jiangsu Hengrui Pharmaceuticals Co., Ltd. › 2025-2026

Jiangsu Hengrui Pharmaceuticals Co., Ltd. 2025-2026 Proxy Voting Records

At Jiangsu Hengrui Pharmaceuticals Co., Ltd.'s 3 shareholder meetings in the 2025-2026 proxy season (held September 16, 2025, December 31, 2025 and April 16, 2026), 79 asset managers reported how they voted in their SEC Form N-PX filings, covering 5,000 separate fund positions. Their filings are grouped here into 95 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. No official Form 8-K vote tally has been matched to this meeting, so this page states no certified outcome for its most widely held ballot item. On that item — Adopt Management Policy for Remuneration of Directors and Senior Management Members — the reporting funds and managers cast 100% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). Fund and manager reports are combined in it and may count the same shares twice: it adds fund reports to institutional-manager reports, which can cover the same shares. It is not the company's certified result.

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings. Page generated November 8, 2026.

  • 95Reported items
  • 79Asset managers
  • 5,000Fund votes
  • April 16, 2026Main meeting date

Results at a glance

No official results are on file for this meeting: no Form 8-K tally (Item 5.07) from Jiangsu Hengrui Pharmaceuticals Co., Ltd. has been matched to it. The figures below are the funds’ own votes from Form N-PX. They are not the meeting result, so they are not used to judge dissent.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2025-2026

Explore Jiangsu Hengrui Pharmaceuticals Co., Ltd. in the interactive database Compare manager voting policies

How asset managers voted at the Jiangsu Hengrui Pharmaceuticals Co., Ltd. 2025-2026 meetings

Each item below shows how the 79 asset managers that disclosed a Jiangsu Hengrui Pharmaceuticals Co., Ltd. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Jiangsu Hengrui Pharmaceuticals Co., Ltd.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Elect Chow Kyan Mervyn as Director

No official resultsDIRECTOR ELECTIONS

Meeting held April 16, 2026; no official results are on file for this meeting.

99.9% of fund votes cast · no official result

FOR
Details: votes by 51 asset managers

The 51 asset managers below reported 88,807,381 for, 25,300 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 88,807,381AGAINST: 25,300
Largest asset managers voting on “Elect Chow Kyan Mervyn as Director” at Jiangsu Hengrui Pharmaceuticals Co., Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Capital Group26,954,4750 00For
Vanguard17,429,6650 00For
BlackRock10,653,3220 00For
EUPAC FUND8,000,4690 00For
Fidelity7,056,6070 00For
T. Rowe Price2,710,8600 00For
MATTHEWS INTERNATIONAL FUNDS1,508,9810 00For
State Street1,239,5720 00For
Morgan Stanley1,174,4020 00For
INTERNATIONAL GROWTH & INCOME FUND1,146,2400 00For
American Century1,113,6800 00For
Northwestern Mutual1,039,9000 00For
JPMorgan966,2750 00For
Goldman Sachs926,0660 00For
WisdomTree886,7810 00For
Aberdeen692,3000 00For
TIAA526,4120 00For
EMERGING MARKETS EQUITIES FUND INC499,7700 00For
Dimensional416,8550 00For
TEMPLETON DRAGON FUND INC407,3600 00For
WILLIAM BLAIR FUNDS400,2000 00For
AIG/SunAmerica399,9000 00For
GuideStone365,7890 00For
ALGER FUNDS347,2810 00For
Dodge & Cox304,5940 00For

Showing the 25 largest of 51 asset managers. All 51 are in the interactive database (link above).

2. Elect Dai Hongbin as Director

No official resultsDIRECTOR ELECTIONSCOMPENSATION

Meeting held April 16, 2026; no official results are on file for this meeting.

93% of fund votes cast · no official result

FOR
Details: votes by 51 asset managers

The 51 asset managers below reported 82,915,038 for, 5,917,643 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 82,915,038AGAINST: 5,917,643
Largest asset managers voting on “Elect Dai Hongbin as Director” at Jiangsu Hengrui Pharmaceuticals Co., Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Capital Group26,954,4750 00For
Vanguard17,429,6650 00For
BlackRock10,653,3220 00For
EUPAC FUND8,000,4690 00For
Fidelity1,805,3625,251,245 00Mixed
T. Rowe Price2,710,8600 00For
MATTHEWS INTERNATIONAL FUNDS1,508,9810 00For
State Street1,239,5720 00For
Morgan Stanley1,174,4020 00For
INTERNATIONAL GROWTH & INCOME FUND1,146,2400 00For
American Century1,113,6800 00For
Northwestern Mutual1,039,9000 00For
JPMorgan966,2750 00For
Goldman Sachs926,0660 00For
WisdomTree886,7810 00For
Aberdeen692,3000 00For
TIAA0526,412 00Against
EMERGING MARKETS EQUITIES FUND INC499,7700 00For
Dimensional416,8550 00For
TEMPLETON DRAGON FUND INC407,3600 00For
WILLIAM BLAIR FUNDS400,2000 00For
AIG/SunAmerica399,9000 00For
GuideStone365,7890 00For
ALGER FUNDS347,2810 00For
Dodge & Cox304,5940 00For

Showing the 25 largest of 51 asset managers. All 51 are in the interactive database (link above).

3. Elect Feng Ji as Director

No official resultsDIRECTOR ELECTIONSCOMPENSATION

Meeting held April 16, 2026; no official results are on file for this meeting.

94% of fund votes cast · no official result

FOR
Details: votes by 51 asset managers

The 51 asset managers below reported 83,556,136 for, 5,276,545 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 83,556,136AGAINST: 5,276,545
Largest asset managers voting on “Elect Feng Ji as Director” at Jiangsu Hengrui Pharmaceuticals Co., Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Capital Group26,954,4750 00For
Vanguard17,429,6650 00For
BlackRock10,653,3220 00For
EUPAC FUND8,000,4690 00For
Fidelity1,805,3625,251,245 00Mixed
T. Rowe Price2,710,8600 00For
MATTHEWS INTERNATIONAL FUNDS1,508,9810 00For
State Street1,239,5720 00For
Morgan Stanley1,174,4020 00For
INTERNATIONAL GROWTH & INCOME FUND1,146,2400 00For
American Century1,113,6800 00For
Northwestern Mutual1,039,9000 00For
JPMorgan966,2750 00For
Goldman Sachs926,0660 00For
WisdomTree886,7810 00For
Aberdeen692,3000 00For
TIAA526,4120 00For
EMERGING MARKETS EQUITIES FUND INC499,7700 00For
Dimensional416,8550 00For
TEMPLETON DRAGON FUND INC407,3600 00For
WILLIAM BLAIR FUNDS400,2000 00For
AIG/SunAmerica399,9000 00For
GuideStone365,7890 00For
ALGER FUNDS347,2810 00For
Dodge & Cox304,5940 00For

Showing the 25 largest of 51 asset managers. All 51 are in the interactive database (link above).

4. Elect Guo Congzhao as Director

No official resultsDIRECTOR ELECTIONSCOMPENSATION

Meeting held April 16, 2026; no official results are on file for this meeting.

94% of fund votes cast · no official result

FOR
Details: votes by 51 asset managers

The 51 asset managers below reported 83,556,136 for, 5,276,545 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 83,556,136AGAINST: 5,276,545
Largest asset managers voting on “Elect Guo Congzhao as Director” at Jiangsu Hengrui Pharmaceuticals Co., Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Capital Group26,954,4750 00For
Vanguard17,429,6650 00For
BlackRock10,653,3220 00For
EUPAC FUND8,000,4690 00For
Fidelity1,805,3625,251,245 00Mixed
T. Rowe Price2,710,8600 00For
MATTHEWS INTERNATIONAL FUNDS1,508,9810 00For
State Street1,239,5720 00For
Morgan Stanley1,174,4020 00For
INTERNATIONAL GROWTH & INCOME FUND1,146,2400 00For
American Century1,113,6800 00For
Northwestern Mutual1,039,9000 00For
JPMorgan966,2750 00For
Goldman Sachs926,0660 00For
WisdomTree886,7810 00For
Aberdeen692,3000 00For
TIAA526,4120 00For
EMERGING MARKETS EQUITIES FUND INC499,7700 00For
Dimensional416,8550 00For
TEMPLETON DRAGON FUND INC407,3600 00For
WILLIAM BLAIR FUNDS400,2000 00For
AIG/SunAmerica399,9000 00For
GuideStone365,7890 00For
ALGER FUNDS347,2810 00For
Dodge & Cox304,5940 00For

Showing the 25 largest of 51 asset managers. All 51 are in the interactive database (link above).

5. Elect Jiang Frank Ningjun as Director

No official resultsDIRECTOR ELECTIONSCOMPENSATION

Meeting held April 16, 2026; no official results are on file for this meeting.

94% of fund votes cast · no official result

FOR
Details: votes by 51 asset managers

The 51 asset managers below reported 83,556,136 for, 5,276,545 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 83,556,136AGAINST: 5,276,545
Largest asset managers voting on “Elect Jiang Frank Ningjun as Director” at Jiangsu Hengrui Pharmaceuticals Co., Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Capital Group26,954,4750 00For
Vanguard17,429,6650 00For
BlackRock10,653,3220 00For
EUPAC FUND8,000,4690 00For
Fidelity1,805,3625,251,245 00Mixed
T. Rowe Price2,710,8600 00For
MATTHEWS INTERNATIONAL FUNDS1,508,9810 00For
State Street1,239,5720 00For
Morgan Stanley1,174,4020 00For
INTERNATIONAL GROWTH & INCOME FUND1,146,2400 00For
American Century1,113,6800 00For
Northwestern Mutual1,039,9000 00For
JPMorgan966,2750 00For
Goldman Sachs926,0660 00For
WisdomTree886,7810 00For
Aberdeen692,3000 00For
TIAA526,4120 00For
EMERGING MARKETS EQUITIES FUND INC499,7700 00For
Dimensional416,8550 00For
TEMPLETON DRAGON FUND INC407,3600 00For
WILLIAM BLAIR FUNDS400,2000 00For
AIG/SunAmerica399,9000 00For
GuideStone365,7890 00For
ALGER FUNDS347,2810 00For
Dodge & Cox304,5940 00For

Showing the 25 largest of 51 asset managers. All 51 are in the interactive database (link above).

6. Elect Lou Liguang as Director

No official resultsDIRECTOR ELECTIONS

Meeting held April 16, 2026; no official results are on file for this meeting.

99.9% of fund votes cast · no official result

FOR
Details: votes by 51 asset managers

The 51 asset managers below reported 88,807,381 for, 25,300 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 88,807,381AGAINST: 25,300
Largest asset managers voting on “Elect Lou Liguang as Director” at Jiangsu Hengrui Pharmaceuticals Co., Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Capital Group26,954,4750 00For
Vanguard17,429,6650 00For
BlackRock10,653,3220 00For
EUPAC FUND8,000,4690 00For
Fidelity7,056,6070 00For
T. Rowe Price2,710,8600 00For
MATTHEWS INTERNATIONAL FUNDS1,508,9810 00For
State Street1,239,5720 00For
Morgan Stanley1,174,4020 00For
INTERNATIONAL GROWTH & INCOME FUND1,146,2400 00For
American Century1,113,6800 00For
Northwestern Mutual1,039,9000 00For
JPMorgan966,2750 00For
Goldman Sachs926,0660 00For
WisdomTree886,7810 00For
Aberdeen692,3000 00For
TIAA526,4120 00For
EMERGING MARKETS EQUITIES FUND INC499,7700 00For
Dimensional416,8550 00For
TEMPLETON DRAGON FUND INC407,3600 00For
WILLIAM BLAIR FUNDS400,2000 00For
AIG/SunAmerica399,9000 00For
GuideStone365,7890 00For
ALGER FUNDS347,2810 00For
Dodge & Cox304,5940 00For

Showing the 25 largest of 51 asset managers. All 51 are in the interactive database (link above).

7. Elect Sun Jinyun as Director

No official resultsDIRECTOR ELECTIONS

Meeting held April 16, 2026; no official results are on file for this meeting.

67% of fund votes cast · no official result

FORAGAINST
Details: votes by 51 asset managers

The 51 asset managers below reported 59,382,786 for, 29,449,895 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 59,382,786AGAINST: 29,449,895
Largest asset managers voting on “Elect Sun Jinyun as Director” at Jiangsu Hengrui Pharmaceuticals Co., Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Capital Group26,954,4750 00For
Vanguard017,429,665 00Against
BlackRock10,653,3220 00For
EUPAC FUND8,000,4690 00For
Fidelity7,056,6070 00For
T. Rowe Price02,710,860 00Against
MATTHEWS INTERNATIONAL FUNDS1,508,9810 00For
State Street01,239,572 00Against
Morgan Stanley1,174,4020 00For
INTERNATIONAL GROWTH & INCOME FUND1,146,2400 00For
American Century01,113,680 00Against
Northwestern Mutual01,039,900 00Against
JPMorgan966,2750 00For
Goldman Sachs0926,066 00Against
WisdomTree0886,781 00Against
Aberdeen0692,300 00Against
TIAA526,4120 00For
EMERGING MARKETS EQUITIES FUND INC499,7700 00For
Dimensional0416,855 00Against
TEMPLETON DRAGON FUND INC0407,360 00Against
WILLIAM BLAIR FUNDS0400,200 00Against
AIG/SunAmerica0399,900 00Against
GuideStone0365,789 00Against
ALGER FUNDS0347,281 00Against
Dodge & Cox304,5940 00For

Showing the 25 largest of 51 asset managers. All 51 are in the interactive database (link above).

8. Elect Sun Piaoyang as Director

No official resultsDIRECTOR ELECTIONSCOMPENSATION

Meeting held April 16, 2026; no official results are on file for this meeting.

93% of fund votes cast · no official result

FOR
Details: votes by 51 asset managers

The 51 asset managers below reported 82,992,015 for, 5,840,666 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 82,992,015AGAINST: 5,840,666
Largest asset managers voting on “Elect Sun Piaoyang as Director” at Jiangsu Hengrui Pharmaceuticals Co., Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Capital Group26,954,4750 00For
Vanguard17,429,6650 00For
BlackRock10,653,3220 00For
EUPAC FUND8,000,4690 00For
Fidelity1,805,3625,251,245 00Mixed
T. Rowe Price2,710,8600 00For
MATTHEWS INTERNATIONAL FUNDS1,508,9810 00For
State Street1,239,5720 00For
Morgan Stanley1,174,4020 00For
INTERNATIONAL GROWTH & INCOME FUND1,146,2400 00For
American Century1,113,6800 00For
Northwestern Mutual1,039,9000 00For
JPMorgan966,2750 00For
Goldman Sachs909,06617,000 00For
WisdomTree886,7810 00For
Aberdeen692,3000 00For
TIAA526,4120 00For
EMERGING MARKETS EQUITIES FUND INC499,7700 00For
Dimensional416,8550 00For
TEMPLETON DRAGON FUND INC407,3600 00For
WILLIAM BLAIR FUNDS400,2000 00For
AIG/SunAmerica399,9000 00For
GuideStone365,7890 00For
ALGER FUNDS0347,281 00Against
Dodge & Cox304,5940 00For

Showing the 25 largest of 51 asset managers. All 51 are in the interactive database (link above).

9. Elect Zeng Qingsheng as Director

No official resultsDIRECTOR ELECTIONS

Meeting held April 16, 2026; no official results are on file for this meeting.

58% of fund votes cast · no official result

FORAGAINST
Details: votes by 51 asset managers

The 51 asset managers below reported 51,179,251 for, 37,653,430 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 51,179,251AGAINST: 37,653,430
Largest asset managers voting on “Elect Zeng Qingsheng as Director” at Jiangsu Hengrui Pharmaceuticals Co., Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Capital Group26,954,4750 00For
Vanguard017,429,665 00Against
BlackRock010,653,322 00Against
EUPAC FUND8,000,4690 00For
Fidelity7,056,6070 00For
T. Rowe Price2,710,8600 00For
MATTHEWS INTERNATIONAL FUNDS1,508,9810 00For
State Street01,239,572 00Against
Morgan Stanley1,160,90113,501 00For
INTERNATIONAL GROWTH & INCOME FUND1,146,2400 00For
American Century01,113,680 00Against
Northwestern Mutual01,039,900 00Against
JPMorgan966,2750 00For
Goldman Sachs0926,066 00Against
WisdomTree0886,781 00Against
Aberdeen0692,300 00Against
TIAA526,4120 00For
EMERGING MARKETS EQUITIES FUND INC499,7700 00For
Dimensional0416,855 00Against
TEMPLETON DRAGON FUND INC0407,360 00Against
WILLIAM BLAIR FUNDS0400,200 00Against
AIG/SunAmerica0399,900 00Against
GuideStone0365,789 00Against
ALGER FUNDS0347,281 00Against
Dodge & Cox304,5940 00For

Showing the 25 largest of 51 asset managers. All 51 are in the interactive database (link above).

10. Elect Zhang Lianshan as Director

No official resultsDIRECTOR ELECTIONSCOMPENSATION

Meeting held April 16, 2026; no official results are on file for this meeting.

94% of fund votes cast · no official result

FOR
Details: votes by 51 asset managers

The 51 asset managers below reported 83,556,136 for, 5,276,545 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 83,556,136AGAINST: 5,276,545
Largest asset managers voting on “Elect Zhang Lianshan as Director” at Jiangsu Hengrui Pharmaceuticals Co., Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Capital Group26,954,4750 00For
Vanguard17,429,6650 00For
BlackRock10,653,3220 00For
EUPAC FUND8,000,4690 00For
Fidelity1,805,3625,251,245 00Mixed
T. Rowe Price2,710,8600 00For
MATTHEWS INTERNATIONAL FUNDS1,508,9810 00For
State Street1,239,5720 00For
Morgan Stanley1,174,4020 00For
INTERNATIONAL GROWTH & INCOME FUND1,146,2400 00For
American Century1,113,6800 00For
Northwestern Mutual1,039,9000 00For
JPMorgan966,2750 00For
Goldman Sachs926,0660 00For
WisdomTree886,7810 00For
Aberdeen692,3000 00For
TIAA526,4120 00For
EMERGING MARKETS EQUITIES FUND INC499,7700 00For
Dimensional416,8550 00For
TEMPLETON DRAGON FUND INC407,3600 00For
WILLIAM BLAIR FUNDS400,2000 00For
AIG/SunAmerica399,9000 00For
GuideStone365,7890 00For
ALGER FUNDS347,2810 00For
Dodge & Cox304,5940 00For

Showing the 25 largest of 51 asset managers. All 51 are in the interactive database (link above).

11. Elect DAI Hongbin

No official resultsDIRECTOR ELECTIONS

Meeting held April 16, 2026; no official results are on file for this meeting.

Combines 2 wordings of this item as funds reported it.

99.9% of fund votes cast · no official result

FOR
Details: votes by 14 asset managers

The 14 asset managers below reported 9,726,041 for, 8,000 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 9,726,041AGAINST: 8,000
Largest asset managers voting on “Elect DAI Hongbin” at Jiangsu Hengrui Pharmaceuticals Co., Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Hartford4,777,7360 00For
Fidelity1,870,5600 00For
BlackRock1,016,0600 00For
Krane Shares Trust874,2950 00For
Charles Schwab532,5440 00For
Russell Investments327,8370 00For
John Hancock96,5490 00For
Jackson National75,6600 00For
New York Life67,4000 00For
Rayliant Funds Trust34,2000 00For
Goldman Sachs24,9000 00For
Neuberger Berman23,5000 00For
Federated Hermes08,000 00Against
Venerable Variable Insurance Trust4,8000 00For

12. Elect GUO Congzhao

No official resultsDIRECTOR ELECTIONS

Meeting held April 16, 2026; no official results are on file for this meeting.

Combines 2 wordings of this item as funds reported it.

99.9% of fund votes cast · no official result

FOR
Details: votes by 14 asset managers

The 14 asset managers below reported 9,726,041 for, 8,000 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 9,726,041AGAINST: 8,000
Largest asset managers voting on “Elect GUO Congzhao” at Jiangsu Hengrui Pharmaceuticals Co., Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Hartford4,777,7360 00For
Fidelity1,870,5600 00For
BlackRock1,016,0600 00For
Krane Shares Trust874,2950 00For
Charles Schwab532,5440 00For
Russell Investments327,8370 00For
John Hancock96,5490 00For
Jackson National75,6600 00For
New York Life67,4000 00For
Rayliant Funds Trust34,2000 00For
Goldman Sachs24,9000 00For
Neuberger Berman23,5000 00For
Federated Hermes08,000 00Against
Venerable Variable Insurance Trust4,8000 00For

13. Elect JIANG Ningjun

No official resultsDIRECTOR ELECTIONS

Meeting held April 16, 2026; no official results are on file for this meeting.

Combines 2 wordings of this item as funds reported it.

100% of fund votes cast · no official result

FOR
Details: votes by 14 asset managers

The 14 asset managers below reported 9,734,041 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 9,734,041
Largest asset managers voting on “Elect JIANG Ningjun” at Jiangsu Hengrui Pharmaceuticals Co., Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Hartford4,777,7360 00For
Fidelity1,870,5600 00For
BlackRock1,016,0600 00For
Krane Shares Trust874,2950 00For
Charles Schwab532,5440 00For
Russell Investments327,8370 00For
John Hancock96,5490 00For
Jackson National75,6600 00For
New York Life67,4000 00For
Rayliant Funds Trust34,2000 00For
Goldman Sachs24,9000 00For
Neuberger Berman23,5000 00For
Federated Hermes8,0000 00For
Venerable Variable Insurance Trust4,8000 00For

14. Elect LOU Liguang

No official resultsDIRECTOR ELECTIONS

Meeting held April 16, 2026; no official results are on file for this meeting.

Combines 2 wordings of this item as funds reported it.

100% of fund votes cast · no official result

FOR
Details: votes by 14 asset managers

The 14 asset managers below reported 9,734,041 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 9,734,041
Largest asset managers voting on “Elect LOU Liguang” at Jiangsu Hengrui Pharmaceuticals Co., Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Hartford4,777,7360 00For
Fidelity1,870,5600 00For
BlackRock1,016,0600 00For
Krane Shares Trust874,2950 00For
Charles Schwab532,5440 00For
Russell Investments327,8370 00For
John Hancock96,5490 00For
Jackson National75,6600 00For
New York Life67,4000 00For
Rayliant Funds Trust34,2000 00For
Goldman Sachs24,9000 00For
Neuberger Berman23,5000 00For
Federated Hermes8,0000 00For
Venerable Variable Insurance Trust4,8000 00For

15. Elect SUN Jinyun

No official resultsDIRECTOR ELECTIONS

Meeting held April 16, 2026; no official results are on file for this meeting.

Combines 2 wordings of this item as funds reported it.

99% of fund votes cast · no official result

FOR
Details: votes by 14 asset managers

The 14 asset managers below reported 9,593,132 for, 140,909 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 9,593,132AGAINST: 140,909
Largest asset managers voting on “Elect SUN Jinyun” at Jiangsu Hengrui Pharmaceuticals Co., Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Hartford4,777,7360 00For
Fidelity1,870,5600 00For
BlackRock1,016,0600 00For
Krane Shares Trust874,2950 00For
Charles Schwab532,5440 00For
Russell Investments327,8370 00For
John Hancock096,549 00Against
Jackson National31,30044,360 00Mixed
New York Life67,4000 00For
Rayliant Funds Trust34,2000 00For
Goldman Sachs24,9000 00For
Neuberger Berman23,5000 00For
Federated Hermes8,0000 00For
Venerable Variable Insurance Trust4,8000 00For

16. Elect SUN Piaoyang

No official resultsDIRECTOR ELECTIONS

Meeting held April 16, 2026; no official results are on file for this meeting.

Combines 2 wordings of this item as funds reported it.

91% of fund votes cast · no official result

FOR
Details: votes by 14 asset managers

The 14 asset managers below reported 8,851,746 for, 882,295 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 8,851,746AGAINST: 882,295
Largest asset managers voting on “Elect SUN Piaoyang” at Jiangsu Hengrui Pharmaceuticals Co., Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Hartford4,777,7360 00For
Fidelity1,870,5600 00For
BlackRock1,016,0600 00For
Krane Shares Trust0874,295 00Against
Charles Schwab532,5440 00For
Russell Investments327,8370 00For
John Hancock96,5490 00For
Jackson National75,6600 00For
New York Life67,4000 00For
Rayliant Funds Trust34,2000 00For
Goldman Sachs24,9000 00For
Neuberger Berman23,5000 00For
Federated Hermes08,000 00Against
Venerable Variable Insurance Trust4,8000 00For

17. Elect ZENG Qingsheng

No official resultsDIRECTOR ELECTIONS

Meeting held April 16, 2026; no official results are on file for this meeting.

Combines 2 wordings of this item as funds reported it.

79% of fund votes cast · no official result

FORAGAINST
Details: votes by 14 asset managers

The 14 asset managers below reported 7,702,777 for, 2,031,264 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 7,702,777AGAINST: 2,031,264
Largest asset managers voting on “Elect ZENG Qingsheng” at Jiangsu Hengrui Pharmaceuticals Co., Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Hartford4,777,7360 00For
Fidelity1,870,5600 00For
BlackRock01,016,060 00Against
Krane Shares Trust0874,295 00Against
Charles Schwab532,5440 00For
Russell Investments327,8370 00For
John Hancock096,549 00Against
Jackson National31,30044,360 00Mixed
New York Life67,4000 00For
Rayliant Funds Trust34,2000 00For
Goldman Sachs24,9000 00For
Neuberger Berman23,5000 00For
Federated Hermes8,0000 00For
Venerable Variable Insurance Trust4,8000 00For

18. Elect ZHANG Lianshan

No official resultsDIRECTOR ELECTIONS

Meeting held April 16, 2026; no official results are on file for this meeting.

Combines 2 wordings of this item as funds reported it.

100% of fund votes cast · no official result

FOR
Details: votes by 14 asset managers

The 14 asset managers below reported 9,734,041 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 9,734,041
Largest asset managers voting on “Elect ZHANG Lianshan” at Jiangsu Hengrui Pharmaceuticals Co., Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Hartford4,777,7360 00For
Fidelity1,870,5600 00For
BlackRock1,016,0600 00For
Krane Shares Trust874,2950 00For
Charles Schwab532,5440 00For
Russell Investments327,8370 00For
John Hancock96,5490 00For
Jackson National75,6600 00For
New York Life67,4000 00For
Rayliant Funds Trust34,2000 00For
Goldman Sachs24,9000 00For
Neuberger Berman23,5000 00For
Federated Hermes8,0000 00For
Venerable Variable Insurance Trust4,8000 00For

19. Amend Rules of Procedure of the Board

No official resultsCORPORATE GOVERNANCE

Meeting held April 16, 2026; no official results are on file for this meeting.

100% of fund votes cast · no official result

FOR
Details: votes by 51 asset managers

The 51 asset managers below reported 88,832,681 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 88,832,681
Largest asset managers voting on “Amend Rules of Procedure of the Board” at Jiangsu Hengrui Pharmaceuticals Co., Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Capital Group26,954,4750 00For
Vanguard17,429,6650 00For
BlackRock10,653,3220 00For
EUPAC FUND8,000,4690 00For
Fidelity7,056,6070 00For
T. Rowe Price2,710,8600 00For
MATTHEWS INTERNATIONAL FUNDS1,508,9810 00For
State Street1,239,5720 00For
Morgan Stanley1,174,4020 00For
INTERNATIONAL GROWTH & INCOME FUND1,146,2400 00For
American Century1,113,6800 00For
Northwestern Mutual1,039,9000 00For
JPMorgan966,2750 00For
Goldman Sachs926,0660 00For
WisdomTree886,7810 00For
Aberdeen692,3000 00For
TIAA526,4120 00For
EMERGING MARKETS EQUITIES FUND INC499,7700 00For
Dimensional416,8550 00For
TEMPLETON DRAGON FUND INC407,3600 00For
WILLIAM BLAIR FUNDS400,2000 00For
AIG/SunAmerica399,9000 00For
GuideStone365,7890 00For
ALGER FUNDS347,2810 00For
Dodge & Cox304,5940 00For

Showing the 25 largest of 51 asset managers. All 51 are in the interactive database (link above).

20. Amend Rules of Procedure of the Shareholders' Meetings

No official resultsCORPORATE GOVERNANCE

Meeting held April 16, 2026; no official results are on file for this meeting.

100% of fund votes cast · no official result

FOR
Details: votes by 51 asset managers

The 51 asset managers below reported 88,832,681 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 88,832,681
Largest asset managers voting on “Amend Rules of Procedure of the Shareholders' Meetings” at Jiangsu Hengrui Pharmaceuticals Co., Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Capital Group26,954,4750 00For
Vanguard17,429,6650 00For
BlackRock10,653,3220 00For
EUPAC FUND8,000,4690 00For
Fidelity7,056,6070 00For
T. Rowe Price2,710,8600 00For
MATTHEWS INTERNATIONAL FUNDS1,508,9810 00For
State Street1,239,5720 00For
Morgan Stanley1,174,4020 00For
INTERNATIONAL GROWTH & INCOME FUND1,146,2400 00For
American Century1,113,6800 00For
Northwestern Mutual1,039,9000 00For
JPMorgan966,2750 00For
Goldman Sachs926,0660 00For
WisdomTree886,7810 00For
Aberdeen692,3000 00For
TIAA526,4120 00For
EMERGING MARKETS EQUITIES FUND INC499,7700 00For
Dimensional416,8550 00For
TEMPLETON DRAGON FUND INC407,3600 00For
WILLIAM BLAIR FUNDS400,2000 00For
AIG/SunAmerica399,9000 00For
GuideStone365,7890 00For
ALGER FUNDS347,2810 00For
Dodge & Cox304,5940 00For

Showing the 25 largest of 51 asset managers. All 51 are in the interactive database (link above).

21. Amend Articles of Association

No official resultsCORPORATE GOVERNANCE

Meeting held December 31, 2025; no official results are on file for this meeting.

100% of fund votes cast · no official result

FOR
Details: votes by 47 asset managers

The 47 asset managers below reported 74,268,323 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 74,268,323
Largest asset managers voting on “Amend Articles of Association” at Jiangsu Hengrui Pharmaceuticals Co., Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Capital Group25,346,9760 00For
Vanguard18,881,9470 00For
Fidelity6,057,3820 00For
EUPAC FUND3,297,5450 00For
DRIEHAUS MUTUAL FUNDS3,234,8560 00For
T. Rowe Price2,613,3600 00For
American Century1,623,6800 00For
State Street1,193,3720 00For
Morgan Stanley1,045,7790 00For
JPMorgan1,026,0750 00For
Goldman Sachs995,9020 00For
WisdomTree859,0810 00For
INTERNATIONAL GROWTH & INCOME FUND837,7100 00For
DWS825,0640 00For
AllianceBernstein757,9200 00For
EMERGING MARKETS EQUITIES FUND INC569,9700 00For
MATTHEWS INTERNATIONAL FUNDS542,1920 00For
Columbia Threadneedle457,4000 00For
TIAA432,7120 00For
WILLIAM BLAIR FUNDS414,6000 00For
Dimensional358,9550 00For
GuideStone355,1890 00For
ALGER FUNDS353,8950 00For
Lord Abbett305,1070 00For
Equitable242,6040 00For

Showing the 25 largest of 47 asset managers. All 47 are in the interactive database (link above).

22. Amendments to Articles

No official resultsCORPORATE GOVERNANCE

Meeting held December 31, 2025; no official results are on file for this meeting.

100% of fund votes cast · no official result

FOR
Details: votes by 12 asset managers

The 12 asset managers below reported 12,298,630 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 12,298,630
Largest asset managers voting on “Amendments to Articles” at Jiangsu Hengrui Pharmaceuticals Co., Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard10,016,2360 00For
Russell Investments1,022,9360 00For
Charles Schwab720,7440 00For
SEI293,3820 00For
SEI Exchange Traded Funds89,3000 00For
Mercer Funds82,4000 00For
Hartford24,8130 00For
Venerable Variable Insurance Trust21,0000 00For
Neuberger Berman15,4000 00For
Federated Hermes8,1000 00For
Victory Capital4,3180 00For
New York Life10 00For

23. Approve Purchase of Liability Insurance for Directors and Senior Management Members

No official resultsCORPORATE GOVERNANCE

Meeting held April 16, 2026; no official results are on file for this meeting.

100% of fund votes cast · no official result

FOR
Details: votes by 51 asset managers

The 51 asset managers below reported 88,832,681 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 88,832,681
Largest asset managers voting on “Approve Purchase of Liability Insurance for Directors and Senior Management Members” at Jiangsu Hengrui Pharmaceuticals Co., Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Capital Group26,954,4750 00For
Vanguard17,429,6650 00For
BlackRock10,653,3220 00For
EUPAC FUND8,000,4690 00For
Fidelity7,056,6070 00For
T. Rowe Price2,710,8600 00For
MATTHEWS INTERNATIONAL FUNDS1,508,9810 00For
State Street1,239,5720 00For
Morgan Stanley1,174,4020 00For
INTERNATIONAL GROWTH & INCOME FUND1,146,2400 00For
American Century1,113,6800 00For
Northwestern Mutual1,039,9000 00For
JPMorgan966,2750 00For
Goldman Sachs926,0660 00For
WisdomTree886,7810 00For
Aberdeen692,3000 00For
TIAA526,4120 00For
EMERGING MARKETS EQUITIES FUND INC499,7700 00For
Dimensional416,8550 00For
TEMPLETON DRAGON FUND INC407,3600 00For
WILLIAM BLAIR FUNDS400,2000 00For
AIG/SunAmerica399,9000 00For
GuideStone365,7890 00For
ALGER FUNDS347,2810 00For
Dodge & Cox304,5940 00For

Showing the 25 largest of 51 asset managers. All 51 are in the interactive database (link above).

24. Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights

No official resultsCAPITAL STRUCTURE

Meeting held April 16, 2026; no official results are on file for this meeting.

23% of fund votes cast · no official result

FORAGAINST
Details: votes by 51 asset managers

The 51 asset managers below reported 20,140,525 for, 68,692,156 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 20,140,525AGAINST: 68,692,156
Largest asset managers voting on “Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights” at Jiangsu Hengrui Pharmaceuticals Co., Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Capital Group026,954,475 00Against
Vanguard17,429,6650 00For
BlackRock010,653,322 00Against
EUPAC FUND08,000,469 00Against
Fidelity07,056,607 00Against
T. Rowe Price2,710,8600 00For
MATTHEWS INTERNATIONAL FUNDS01,508,981 00Against
State Street01,239,572 00Against
Morgan Stanley01,174,402 00Against
INTERNATIONAL GROWTH & INCOME FUND01,146,240 00Against
American Century01,113,680 00Against
Northwestern Mutual01,039,900 00Against
JPMorgan0966,275 00Against
Goldman Sachs0926,066 00Against
WisdomTree0886,781 00Against
Aberdeen0692,300 00Against
TIAA0526,412 00Against
EMERGING MARKETS EQUITIES FUND INC0499,770 00Against
Dimensional0416,855 00Against
TEMPLETON DRAGON FUND INC0407,360 00Against
WILLIAM BLAIR FUNDS0400,200 00Against
AIG/SunAmerica0399,900 00Against
GuideStone0365,789 00Against
ALGER FUNDS0347,281 00Against
Dodge & Cox0304,594 00Against

Showing the 25 largest of 51 asset managers. All 51 are in the interactive database (link above).

25. Approve Annual Report

No official resultsCORPORATE GOVERNANCE

Meeting held April 16, 2026; no official results are on file for this meeting.

100% of fund votes cast · no official result

FOR
Details: votes by 51 asset managers

The 51 asset managers below reported 88,832,681 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 88,832,681
Largest asset managers voting on “Approve Annual Report” at Jiangsu Hengrui Pharmaceuticals Co., Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Capital Group26,954,4750 00For
Vanguard17,429,6650 00For
BlackRock10,653,3220 00For
EUPAC FUND8,000,4690 00For
Fidelity7,056,6070 00For
T. Rowe Price2,710,8600 00For
MATTHEWS INTERNATIONAL FUNDS1,508,9810 00For
State Street1,239,5720 00For
Morgan Stanley1,174,4020 00For
INTERNATIONAL GROWTH & INCOME FUND1,146,2400 00For
American Century1,113,6800 00For
Northwestern Mutual1,039,9000 00For
JPMorgan966,2750 00For
Goldman Sachs926,0660 00For
WisdomTree886,7810 00For
Aberdeen692,3000 00For
TIAA526,4120 00For
EMERGING MARKETS EQUITIES FUND INC499,7700 00For
Dimensional416,8550 00For
TEMPLETON DRAGON FUND INC407,3600 00For
WILLIAM BLAIR FUNDS400,2000 00For
AIG/SunAmerica399,9000 00For
GuideStone365,7890 00For
ALGER FUNDS347,2810 00For
Dodge & Cox304,5940 00For

Showing the 25 largest of 51 asset managers. All 51 are in the interactive database (link above).

26. Approve Work Report of the Board of Directors

No official resultsCORPORATE GOVERNANCE

Meeting held April 16, 2026; no official results are on file for this meeting.

100% of fund votes cast · no official result

FOR
Details: votes by 51 asset managers

The 51 asset managers below reported 88,832,681 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 88,832,681
Largest asset managers voting on “Approve Work Report of the Board of Directors” at Jiangsu Hengrui Pharmaceuticals Co., Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Capital Group26,954,4750 00For
Vanguard17,429,6650 00For
BlackRock10,653,3220 00For
EUPAC FUND8,000,4690 00For
Fidelity7,056,6070 00For
T. Rowe Price2,710,8600 00For
MATTHEWS INTERNATIONAL FUNDS1,508,9810 00For
State Street1,239,5720 00For
Morgan Stanley1,174,4020 00For
INTERNATIONAL GROWTH & INCOME FUND1,146,2400 00For
American Century1,113,6800 00For
Northwestern Mutual1,039,9000 00For
JPMorgan966,2750 00For
Goldman Sachs926,0660 00For
WisdomTree886,7810 00For
Aberdeen692,3000 00For
TIAA526,4120 00For
EMERGING MARKETS EQUITIES FUND INC499,7700 00For
Dimensional416,8550 00For
TEMPLETON DRAGON FUND INC407,3600 00For
WILLIAM BLAIR FUNDS400,2000 00For
AIG/SunAmerica399,9000 00For
GuideStone365,7890 00For
ALGER FUNDS347,2810 00For
Dodge & Cox304,5940 00For

Showing the 25 largest of 51 asset managers. All 51 are in the interactive database (link above).

27. Annual Report

No official resultsCORPORATE GOVERNANCE

Meeting held April 16, 2026; no official results are on file for this meeting.

100% of fund votes cast · no official result

FOR
Details: votes by 14 asset managers

The 14 asset managers below reported 9,734,041 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 9,734,041
Largest asset managers voting on “Annual Report” at Jiangsu Hengrui Pharmaceuticals Co., Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Hartford4,777,7360 00For
Fidelity1,870,5600 00For
BlackRock1,016,0600 00For
Krane Shares Trust874,2950 00For
Charles Schwab532,5440 00For
Russell Investments327,8370 00For
John Hancock96,5490 00For
Jackson National75,6600 00For
New York Life67,4000 00For
Rayliant Funds Trust34,2000 00For
Goldman Sachs24,9000 00For
Neuberger Berman23,5000 00For
Federated Hermes8,0000 00For
Venerable Variable Insurance Trust4,8000 00For

28. Adopt Management Policy for Remuneration of Directors and Senior Management Members

Meeting held April 16, 2026; no official results are on file for this meeting.

100% Fund and manager reports combined; may count the same shares twice · no official result

FOR
Details: votes by 52 asset managers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 51 asset managers voting on “Adopt Management Policy for Remuneration of Directors and Senior Management Members” at Jiangsu Hengrui Pharmaceuticals Co., Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Capital Group26,954,4750 00For
Vanguard17,429,6650 00For
BlackRock10,653,3220 00For
EUPAC FUND8,000,4690 00For
Fidelity7,056,6070 00For
T. Rowe Price2,710,8600 00For
MATTHEWS INTERNATIONAL FUNDS1,508,9810 00For
State Street1,239,5720 00For
Morgan Stanley1,174,4020 00For
INTERNATIONAL GROWTH & INCOME FUND1,146,2400 00For
American Century1,113,6800 00For
Northwestern Mutual1,039,9000 00For
JPMorgan966,2750 00For
Goldman Sachs926,0660 00For
WisdomTree886,7810 00For
Aberdeen692,3000 00For
TIAA526,4120 00For
EMERGING MARKETS EQUITIES FUND INC499,7700 00For
Dimensional416,8550 00For
TEMPLETON DRAGON FUND INC407,3600 00For
WILLIAM BLAIR FUNDS400,2000 00For
AIG/SunAmerica399,9000 00For
GuideStone365,7890 00For
ALGER FUNDS347,2810 00For
Dodge & Cox304,5940 00For

Fund voting reports, all 51 managers: 88,832,681 for. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 1 asset manager voting on “Adopt Management Policy for Remuneration of Directors and Senior Management Members” at Jiangsu Hengrui Pharmaceuticals Co., Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Ghisallo Capital Management LLC2,936,6000 00For

Institutional-manager reports, all 1 managers: 2,936,600 for.

29. Approve Remuneration Plan for the Directors and Senior Management Members

Meeting held April 16, 2026; no official results are on file for this meeting.

100% Fund and manager reports combined; may count the same shares twice · no official result

FOR
Details: votes by 52 asset managers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 51 asset managers voting on “Approve Remuneration Plan for the Directors and Senior Management Members” at Jiangsu Hengrui Pharmaceuticals Co., Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Capital Group26,954,4750 00For
Vanguard17,429,6650 00For
BlackRock10,653,3220 00For
EUPAC FUND8,000,4690 00For
Fidelity7,056,6070 00For
T. Rowe Price2,710,8600 00For
MATTHEWS INTERNATIONAL FUNDS1,508,9810 00For
State Street1,239,5720 00For
Morgan Stanley1,174,4020 00For
INTERNATIONAL GROWTH & INCOME FUND1,146,2400 00For
American Century1,113,6800 00For
Northwestern Mutual1,039,9000 00For
JPMorgan966,2750 00For
Goldman Sachs926,0660 00For
WisdomTree886,7810 00For
Aberdeen692,3000 00For
TIAA526,4120 00For
EMERGING MARKETS EQUITIES FUND INC499,7700 00For
Dimensional416,8550 00For
TEMPLETON DRAGON FUND INC407,3600 00For
WILLIAM BLAIR FUNDS400,2000 00For
AIG/SunAmerica399,9000 00For
GuideStone365,7890 00For
ALGER FUNDS347,2810 00For
Dodge & Cox304,5940 00For

Fund voting reports, all 51 managers: 88,832,681 for. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 1 asset manager voting on “Approve Remuneration Plan for the Directors and Senior Management Members” at Jiangsu Hengrui Pharmaceuticals Co., Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Ghisallo Capital Management LLC2,936,6000 00For

Institutional-manager reports, all 1 managers: 2,936,600 for.

30. Approve Remuneration of Directors and Senior Management Members

Meeting held April 16, 2026; no official results are on file for this meeting.

94% Fund and manager reports combined; may count the same shares twice · no official result

FOR
Details: votes by 52 asset managers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 51 asset managers voting on “Approve Remuneration of Directors and Senior Management Members” at Jiangsu Hengrui Pharmaceuticals Co., Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Capital Group26,954,4750 00For
Vanguard17,429,6650 00For
BlackRock10,653,3220 00For
EUPAC FUND8,000,4690 00For
Fidelity1,805,3625,251,245 00Mixed
T. Rowe Price2,710,8600 00For
MATTHEWS INTERNATIONAL FUNDS1,508,9810 00For
State Street1,239,5720 00For
Morgan Stanley1,174,4020 00For
INTERNATIONAL GROWTH & INCOME FUND1,146,2400 00For
American Century1,113,6800 00For
Northwestern Mutual1,039,9000 00For
JPMorgan966,2750 00For
Goldman Sachs926,0660 00For
WisdomTree886,7810 00For
Aberdeen692,3000 00For
TIAA526,4120 00For
EMERGING MARKETS EQUITIES FUND INC499,7700 00For
Dimensional416,8550 00For
TEMPLETON DRAGON FUND INC407,3600 00For
WILLIAM BLAIR FUNDS400,2000 00For
AIG/SunAmerica399,9000 00For
GuideStone365,7890 00For
ALGER FUNDS347,2810 00For
Dodge & Cox304,5940 00For

Fund voting reports, all 51 managers: 83,581,436 for, 5,251,245 against. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 1 asset manager voting on “Approve Remuneration of Directors and Senior Management Members” at Jiangsu Hengrui Pharmaceuticals Co., Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Ghisallo Capital Management LLC2,936,6000 00For

Institutional-manager reports, all 1 managers: 2,936,600 for.

31. Approve Profit Distribution Plan and Authorize Board to Formulate the Company's Interim Dividend Plan

No official resultsCAPITAL STRUCTURE

Meeting held April 16, 2026; no official results are on file for this meeting.

100% of fund votes cast · no official result

FOR
Details: votes by 51 asset managers

The 51 asset managers below reported 88,832,681 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 88,832,681
Largest asset managers voting on “Approve Profit Distribution Plan and Authorize Board to Formulate the Company's Interim Dividend Plan” at Jiangsu Hengrui Pharmaceuticals Co., Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Capital Group26,954,4750 00For
Vanguard17,429,6650 00For
BlackRock10,653,3220 00For
EUPAC FUND8,000,4690 00For
Fidelity7,056,6070 00For
T. Rowe Price2,710,8600 00For
MATTHEWS INTERNATIONAL FUNDS1,508,9810 00For
State Street1,239,5720 00For
Morgan Stanley1,174,4020 00For
INTERNATIONAL GROWTH & INCOME FUND1,146,2400 00For
American Century1,113,6800 00For
Northwestern Mutual1,039,9000 00For
JPMorgan966,2750 00For
Goldman Sachs926,0660 00For
WisdomTree886,7810 00For
Aberdeen692,3000 00For
TIAA526,4120 00For
EMERGING MARKETS EQUITIES FUND INC499,7700 00For
Dimensional416,8550 00For
TEMPLETON DRAGON FUND INC407,3600 00For
WILLIAM BLAIR FUNDS400,2000 00For
AIG/SunAmerica399,9000 00For
GuideStone365,7890 00For
ALGER FUNDS347,2810 00For
Dodge & Cox304,5940 00For

Showing the 25 largest of 51 asset managers. All 51 are in the interactive database (link above).

32. Adopt 2025 A Share Employee Stock Ownership Scheme

Meeting held September 16, 2025; no official results are on file for this meeting.

90% of fund votes cast · no official result

FOR
Details: votes by 48 asset managers

The 48 asset managers below reported 74,382,632 for, 8,012,038 against, 13,195,200 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 74,382,632AGAINST: 8,012,038ABSTAIN: 13,195,200
Largest asset managers voting on “Adopt 2025 A Share Employee Stock Ownership Scheme” at Jiangsu Hengrui Pharmaceuticals Co., Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Capital Group26,545,1210 00For
Vanguard13,664,3470 00For
Invesco00 13,195,2000Abstain
EUPAC FUND6,942,2000 00For
T. Rowe Price6,590,1600 00For
Fidelity06,007,592 00Against
DRIEHAUS MUTUAL FUNDS4,858,3960 00For
INTERNATIONAL GROWTH & INCOME FUND1,769,8000 00For
American Century1,753,9800 00For
Goldman Sachs01,666,946 00Against
WisdomTree1,149,2810 00For
State Street1,113,4720 00For
Morgan Stanley1,039,4690 00For
JPMorgan1,003,7750 00For
MATTHEWS INTERNATIONAL FUNDS911,1920 00For
DWS824,3520 00For
EMERGING MARKETS EQUITIES FUND INC758,7700 00For
Columbia Threadneedle691,7370 00For
AllianceBernstein501,0600 00For
TIAA485,8120 00For
GuideStone483,3580 00For
WILLIAM BLAIR FUNDS448,6000 00For
Empower113,600334,600 00Mixed
Dimensional381,7550 00For
ALGER FUNDS353,8950 00For

Showing the 25 largest of 48 asset managers. All 48 are in the interactive database (link above).

33. Adopt Administrative Measures for the 2025 A Share Employee Stock Ownership Scheme

Meeting held September 16, 2025; no official results are on file for this meeting.

90% of fund votes cast · no official result

FOR
Details: votes by 48 asset managers

The 48 asset managers below reported 74,382,632 for, 8,012,038 against, 13,195,200 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 74,382,632AGAINST: 8,012,038ABSTAIN: 13,195,200
Largest asset managers voting on “Adopt Administrative Measures for the 2025 A Share Employee Stock Ownership Scheme” at Jiangsu Hengrui Pharmaceuticals Co., Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Capital Group26,545,1210 00For
Vanguard13,664,3470 00For
Invesco00 13,195,2000Abstain
EUPAC FUND6,942,2000 00For
T. Rowe Price6,590,1600 00For
Fidelity06,007,592 00Against
DRIEHAUS MUTUAL FUNDS4,858,3960 00For
INTERNATIONAL GROWTH & INCOME FUND1,769,8000 00For
American Century1,753,9800 00For
Goldman Sachs01,666,946 00Against
WisdomTree1,149,2810 00For
State Street1,113,4720 00For
Morgan Stanley1,039,4690 00For
JPMorgan1,003,7750 00For
MATTHEWS INTERNATIONAL FUNDS911,1920 00For
DWS824,3520 00For
EMERGING MARKETS EQUITIES FUND INC758,7700 00For
Columbia Threadneedle691,7370 00For
AllianceBernstein501,0600 00For
TIAA485,8120 00For
GuideStone483,3580 00For
WILLIAM BLAIR FUNDS448,6000 00For
Empower113,600334,600 00Mixed
Dimensional381,7550 00For
ALGER FUNDS353,8950 00For

Showing the 25 largest of 48 asset managers. All 48 are in the interactive database (link above).

34. Approve Authorization of the Board to Deal with All Matters in Relation to the 2025 A Share Employee Stock Ownership…

Meeting held September 16, 2025; no official results are on file for this meeting.

90% of fund votes cast · no official result

FOR
Details: description as filed, votes by 48 asset managers

Description as filed by funds: Approve Authorization of the Board to Deal with All Matters in Relation to the 2025 A Share Employee Stock Ownership Scheme

The 48 asset managers below reported 74,382,632 for, 8,012,038 against, 13,195,200 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 74,382,632AGAINST: 8,012,038ABSTAIN: 13,195,200
Largest asset managers voting on “Approve Authorization of the Board to Deal with All Matters in Relation to the 2025 A Share Employee Stock Own” at Jiangsu Hengrui Pharmaceuticals Co., Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Capital Group26,545,1210 00For
Vanguard13,664,3470 00For
Invesco00 13,195,2000Abstain
EUPAC FUND6,942,2000 00For
T. Rowe Price6,590,1600 00For
Fidelity06,007,592 00Against
DRIEHAUS MUTUAL FUNDS4,858,3960 00For
INTERNATIONAL GROWTH & INCOME FUND1,769,8000 00For
American Century1,753,9800 00For
Goldman Sachs01,666,946 00Against
WisdomTree1,149,2810 00For
State Street1,113,4720 00For
Morgan Stanley1,039,4690 00For
JPMorgan1,003,7750 00For
MATTHEWS INTERNATIONAL FUNDS911,1920 00For
DWS824,3520 00For
EMERGING MARKETS EQUITIES FUND INC758,7700 00For
Columbia Threadneedle691,7370 00For
AllianceBernstein501,0600 00For
TIAA485,8120 00For
GuideStone483,3580 00For
WILLIAM BLAIR FUNDS448,6000 00For
Empower113,600334,600 00Mixed
Dimensional381,7550 00For
ALGER FUNDS353,8950 00For

Showing the 25 largest of 48 asset managers. All 48 are in the interactive database (link above).

35. A-Share Employee Stock Ownership Plan (Draft) and Its Summary

Meeting held September 16, 2025; no official results are on file for this meeting.

2% of fund votes cast · no official result

AGAINST
Details: votes by 12 asset managers

The 12 asset managers below reported 71,800 for, 2,812,848 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 71,800AGAINST: 2,812,848
Largest asset managers voting on “A-Share Employee Stock Ownership Plan (Draft) and Its Summary” at Jiangsu Hengrui Pharmaceuticals Co., Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Russell Investments0980,536 00Against
SEI0699,200 00Against
Charles Schwab0554,444 00Against
Hartford0241,268 00Against
SEI Exchange Traded Funds0142,800 00Against
Mercer Funds082,400 00Against
Prudential/PGIM71,8000 00For
Vanguard047,400 00Against
New York Life042,400 00Against
Neuberger Berman012,700 00Against
Federated Hermes08,500 00Against
Victory Capital01,200 00Against

36. Full Board Authorization to Handle Matters Related to 2025 A-Share Employee Stock Ownership Plan

No official resultsCORPORATE GOVERNANCE

Meeting held September 16, 2025; no official results are on file for this meeting.

3% of fund votes cast · no official result

AGAINST
Details: votes by 12 asset managers

The 12 asset managers below reported 80,300 for, 2,804,348 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 80,300AGAINST: 2,804,348
Largest asset managers voting on “Full Board Authorization to Handle Matters Related to 2025 A-Share Employee Stock Ownership Plan” at Jiangsu Hengrui Pharmaceuticals Co., Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Russell Investments0980,536 00Against
SEI0699,200 00Against
Charles Schwab0554,444 00Against
Hartford0241,268 00Against
SEI Exchange Traded Funds0142,800 00Against
Mercer Funds082,400 00Against
Prudential/PGIM71,8000 00For
Vanguard047,400 00Against
New York Life042,400 00Against
Neuberger Berman012,700 00Against
Federated Hermes8,5000 00For
Victory Capital01,200 00Against

37. Management Measures for 2025 A-Share Employee Stock Ownership Plan

No official resultsCORPORATE GOVERNANCE

Meeting held September 16, 2025; no official results are on file for this meeting.

2% of fund votes cast · no official result

AGAINST
Details: votes by 12 asset managers

The 12 asset managers below reported 71,800 for, 2,812,848 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 71,800AGAINST: 2,812,848
Largest asset managers voting on “Management Measures for 2025 A-Share Employee Stock Ownership Plan” at Jiangsu Hengrui Pharmaceuticals Co., Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Russell Investments0980,536 00Against
SEI0699,200 00Against
Charles Schwab0554,444 00Against
Hartford0241,268 00Against
SEI Exchange Traded Funds0142,800 00Against
Mercer Funds082,400 00Against
Prudential/PGIM71,8000 00For
Vanguard047,400 00Against
New York Life042,400 00Against
Neuberger Berman012,700 00Against
Federated Hermes08,500 00Against
Victory Capital01,200 00Against

38. Approve Ernst & Young Hua Ming LLP as Domestic Auditor and Ernst & Young as International Auditor and Authorize Board…

No official resultsAUDIT-RELATED

Meeting held April 16, 2026; no official results are on file for this meeting.

55% of fund votes cast · no official result

FORAGAINST
Details: description as filed, votes by 51 asset managers

Description as filed by funds: Approve Ernst & Young Hua Ming LLP as Domestic Auditor and Ernst & Young as International Auditor and Authorize Board to Fix Their Remuneration

The 51 asset managers below reported 48,848,277 for, 39,922,644 against, 61,760 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 48,848,277AGAINST: 39,922,644ABSTAIN: 61,760
Largest asset managers voting on “Approve Ernst & Young Hua Ming LLP as Domestic Auditor and Ernst & Young as International Auditor and Authoriz” at Jiangsu Hengrui Pharmaceuticals Co., Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Capital Group26,954,4750 00For
Vanguard017,429,665 00Against
BlackRock010,653,322 00Against
EUPAC FUND8,000,4690 00For
Fidelity5,251,2451,805,362 00Mixed
T. Rowe Price2,710,8600 00For
MATTHEWS INTERNATIONAL FUNDS1,508,9810 00For
State Street01,239,572 00Against
Morgan Stanley1,160,90113,501 00For
INTERNATIONAL GROWTH & INCOME FUND1,146,2400 00For
American Century01,113,680 00Against
Northwestern Mutual01,039,900 00Against
JPMorgan966,2750 00For
Goldman Sachs0926,066 00Against
WisdomTree0886,781 00Against
Aberdeen0692,300 00Against
TIAA0526,412 00Against
EMERGING MARKETS EQUITIES FUND INC499,7700 00For
Dimensional0416,855 00Against
TEMPLETON DRAGON FUND INC0407,360 00Against
WILLIAM BLAIR FUNDS0400,200 00Against
AIG/SunAmerica0399,900 00Against
GuideStone0365,789 00Against
ALGER FUNDS0347,281 00Against
Dodge & Cox304,5940 00For

Showing the 25 largest of 51 asset managers. All 51 are in the interactive database (link above).

39. Approve Ernst & Young as International Auditor and Authorize Board to Fix Their Remuneration

No official resultsAUDIT-RELATED

Meeting held September 16, 2025; no official results are on file for this meeting.

100% of fund votes cast · no official result

FORABSTAIN
Details: votes by 48 asset managers

The 48 asset managers below reported 81,891,010 for, 13,698,860 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 81,891,010ABSTAIN: 13,698,860
Largest asset managers voting on “Approve Ernst & Young as International Auditor and Authorize Board to Fix Their Remuneration” at Jiangsu Hengrui Pharmaceuticals Co., Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Capital Group26,545,1210 00For
Vanguard13,664,3470 00For
Invesco00 13,195,2000Abstain
EUPAC FUND6,942,2000 00For
T. Rowe Price6,590,1600 00For
Fidelity6,007,5920 00For
DRIEHAUS MUTUAL FUNDS4,858,3960 00For
INTERNATIONAL GROWTH & INCOME FUND1,769,8000 00For
American Century1,753,9800 00For
Goldman Sachs1,666,9460 00For
WisdomTree1,149,2810 00For
State Street1,113,4720 00For
Morgan Stanley1,039,4690 00For
JPMorgan1,003,7750 00For
MATTHEWS INTERNATIONAL FUNDS911,1920 00For
DWS824,3520 00For
EMERGING MARKETS EQUITIES FUND INC758,7700 00For
Columbia Threadneedle691,7370 00For
AllianceBernstein00 501,0600Abstain
TIAA485,8120 00For
GuideStone483,3580 00For
WILLIAM BLAIR FUNDS448,6000 00For
Empower448,2000 00For
Dimensional381,7550 00For
ALGER FUNDS353,8950 00For

Showing the 25 largest of 48 asset managers. All 48 are in the interactive database (link above).

40. Appointment of 2025 Foreign Auditor

No official resultsAUDIT-RELATED

Meeting held September 16, 2025; no official results are on file for this meeting.

100% of fund votes cast · no official result

FOR
Details: votes by 12 asset managers

The 12 asset managers below reported 2,884,648 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 2,884,648
Largest asset managers voting on “Appointment of 2025 Foreign Auditor” at Jiangsu Hengrui Pharmaceuticals Co., Ltd., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Russell Investments980,5360 00For
SEI699,2000 00For
Charles Schwab554,4440 00For
Hartford241,2680 00For
SEI Exchange Traded Funds142,8000 00For
Mercer Funds82,4000 00For
Prudential/PGIM71,8000 00For
Vanguard47,4000 00For
New York Life42,4000 00For
Neuberger Berman12,7000 00For
Federated Hermes8,5000 00For
Victory Capital1,2000 00For

Showing the 40 reported items with the widest manager coverage, of 95 in total. Every item is in the interactive database (link above).

Largest Jiangsu Hengrui Pharmaceuticals Co., Ltd. shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported.

Fund voting reports: top Jiangsu Hengrui Pharmaceuticals Co., Ltd. shareholders by shares voted on “Adopt Management Policy for Remuneration of Directors and Senior Management Members”, 2025-2026
#Asset manager Shares voted
1Capital Group 26,954,475
2Vanguard 17,429,665
3BlackRock 10,653,322
4EUPAC FUND 8,000,469
5Fidelity 7,056,607
6T. Rowe Price 2,710,860
7MATTHEWS INTERNATIONAL FUNDS 1,508,981
8State Street 1,239,572
9Morgan Stanley 1,174,402
10INTERNATIONAL GROWTH & INCOME FUND 1,146,240
Institutional-manager reports: top Jiangsu Hengrui Pharmaceuticals Co., Ltd. shareholders by shares voted on “Adopt Management Policy for Remuneration of Directors and Senior Management Members”, 2025-2026
#Asset manager Shares voted
1Ghisallo Capital Management LLC 2,936,600

Shown as share counts, not percentages: no shares-outstanding figure has been matched to Jiangsu Hengrui Pharmaceuticals Co., Ltd. for the 2025-2026 season, so there is no denominator to divide by.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.

Jiangsu Hengrui Pharmaceuticals Co., Ltd. proxy season coverage: 2025-2026 (this page).

Cite this page

proxyvotesnow.com, “Jiangsu Hengrui Pharmaceuticals Co., Ltd. 2025-2026 Shareholder Meetings”, https://proxyvotesnow.com/company/jiangsu-hengrui-pharmaceuticals-co-ltd/2026 (version of November 9, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.